The porphyrias: the royal purple?
D000208:Acute Disease; D000890:Anti-Infective Agents / Q000009:adverse effects; D001463:Barbiturates / Q000009:adverse effects; D002118:Calcium / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D002722:Chlorobenzenes / Q000009:adverse effects; D004196:Disease Outbreaks; D004739:England; D005260:Female; D005942:Gluconates / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010375:Pedigree; D011164:Porphyrias / Q000139:chemically induced / Q000150:complications* / Q000235:genetics / Q000628:therapy; D011166:Porphyrins / Q000378:metabolism*; D012965:Sodium Chloride / Q000627:therapeutic use; D013449:Sulfonamides / Q000009:adverse effects; D014421:Turkey
D000890:Anti-Infective Agents; D001463:Barbiturates; D002722:Chlorobenzenes; D005942:Gluconates; D011166:Porphyrins; D013449:Sulfonamides; D012965:Sodium Chloride; D002118:Calcium